|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▼
|
Registration date ▲
|
Status ▲
|
|
SALMETEROL |
R03AC12 |
SI
|
I
|
|
X |
10-05-2007 |
VALID
|
|
SIMVASTATIN |
C10AA01 |
SI
|
POM
|
04-12-2024 |
X |
31-01-2007 |
VALID
|
|
TERBINAFINE |
D01BA02 |
SI
|
I
|
|
X |
14-05-2007 |
VALID
|
|
VALSARTAN AND DIURETICS |
C09DA03 |
SI
|
I
|
|
X |
15-01-2007 |
VALID
|
|
VINORELBINE |
L01CA04 |
SI
|
I
|
|
X |
15-01-2007 |
VALID
|
|
CELECOXIB |
M01AH01 |
SI
|
POM
|
24-10-2017 |
SI/H/0151/002/ |
27-08-2014 |
VALID
|
|
REMIFENTANIL |
N01AH06 |
SI
|
POM
|
01-08-2016 |
SI/H/0148/003/ |
17-06-2014 |
VALID
|
|
MEMANTINE |
N06DX01 |
SI
|
I
|
|
SI/H/0146/002/ |
29-11-2012 |
VALID
|
|
ATORVASTATIN AND AMLODIPINE |
C10BX03 |
SI
|
POM
|
11-12-2024 |
SI/H/0143/002/ |
29-01-2013 |
VALID
|
|
SOLIFENACIN |
G04BD08 |
SI
|
POM
|
28-02-2017 |
SI/H/0137/002/ |
29-04-2015 |
VALID
|
|
EZETIMIBE |
C10AX09 |
SI
|
POM
|
09-12-2024 |
SI/H/0105/001/ |
12-10-2013 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) |
J07BB02 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006538 |
15-11-2024 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
ACORAMIDIS |
C01EB25 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006333 |
10-02-2025 |
VALID
|
|
EPLONTERSEN |
N07XX21 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006295 |
06-03-2025 |
VALID
|
|
SIPAVIBART |
J06BD09 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006291 |
20-01-2025 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
MARSTACIMAB |
B02BX11 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006240 |
19-09-2024 |
VALID
|
|
ELAFIBRANOR |
A05AX06 |
SI
|
Not authorised
|
05-05-2025 |
EMEA/H/C/006231 |
19-09-2024 |
VALID
|
|
DASIGLUCAGON |
H04AA02 |
SI
|
Not authorised
|
05-05-2025 |
EMEA/H/C/006214 |
24-07-2024 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
SI
|
Not authorised
|
05-05-2025 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
SI
|
POM
|
13-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
SERPLULIMAB |
L01FF12 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006170 |
03-02-2025 |
VALID
|
|
NEMOLIZUMAB |
D11AH12 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006149 |
12-02-2025 |
VALID
|
|
VILOBELIMAB |
L04AJ10 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006123 |
13-01-2025 |
VALID
|
|
TORIPALIMAB |
L01FF13 |
SI
|
Not authorised
|
05-05-2025 |
EMEA/H/C/006120 |
19-09-2024 |
VALID
|
|
GARADACIMAB |
B06AC07 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006116 |
10-02-2025 |
VALID
|
|
AZTREONAM AND BETA-LACTAMASE INHIBITOR |
J01DF51 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006113 |
22-04-2024 |
VALID
|
|
DELGOCITINIB |
D11AH11 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006109 |
19-09-2024 |
VALID
|
|
IMETELSTAT |
L01XX80 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006105 |
07-03-2025 |
VALID
|
|
LAZERTINIB |
L01EB09 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006074 |
20-01-2025 |
VALID
|
|
FLORTAUCIPIR (18F) |
V09AX07 |
SI
|
Not authorised
|
05-05-2025 |
EMEA/H/C/006064 |
22-08-2024 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
SI
|
POM
|
06-05-2025 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
DOPAMINE |
C01CA04 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006044 |
27-05-2024 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
SI
|
POM
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
SI
|
POM
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
CAPIVASERTIB |
L01EX27 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
ADAGRASIB |
L01XX77 |
SI
|
Not authorised
|
05-05-2025 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
DANTROLENE |
M03CA01 |
SI
|
Not authorised
|
05-05-2025 |
EMEA/H/C/006009 |
29-05-2024 |
VALID
|
|
ETRASIMOD |
L04AE05 |
SI
|
POM
|
13-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
REPOTRECTINIB |
L01EX28 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/006005 |
13-01-2025 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
SI
|
POM
|
18-08-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
SI
|
POM
|
22-10-2024 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
VIBEGRON |
G04BD15 |
SI
|
Not authorised
|
05-05-2025 |
EMEA/H/C/005957 |
27-06-2024 |
VALID
|
|
CONCIZUMAB |
B02BX10 |
SI
|
POM
|
05-05-2025 |
EMEA/H/C/005938 |
13-12-2024 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
SI
|
POM
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|